Prostate biopsy in Oklahoma: the highest-volume physicians
61 physicians in Oklahoma billed Medicare for 1,598 prostate biopsy procedures in 2024. The top 26, with the year before beside it.
Top 26
| Rank | Physician | 2024 | 2023 | Change |
|---|---|---|---|---|
| 1 | Joseph F. Rodriguez, MDUrology · Oklahoma City | 71 | 57 | +25% |
| 2 | Bradley A. Wilson, MDUrology · Norman | 57 | 48 | +19% |
| 3 | Dae Y. Kim, MD, PHDUrology · Tulsa | 56 | 38 | +47% |
| 4 | Brian A. Link, MDUrology · Oklahoma City | 50 | 36 | +39% |
| 5 | Cole W. Wootton, MDUrology · Elk City | 45 | 43 | +5% |
| 6 | Kelly L. Stratton, MDUrology · Oklahoma City | 44 | 14 | |
| 6 | George S. Law, MDUrology · Midwest City | 44 | 18 | |
| 8 | Marc S. Milsten, MDUrology · Tulsa | 43 | 16 | |
| 9 | Johnny D. Hickson, MDUrology · Oklahoma City | 42 | 13 | |
| 10 | Jeremy C. Carrico, MDUrology · Tulsa | 41 | — | |
| 11 | James R. Colvert, MDUrology · Enid | 37 | 27 | +37% |
| 11 | Thomas M. Rashid, MDUrology · Tulsa | 37 | 33 | +12% |
| 13 | Esber Nabeeh S. Samara, MDUrology · Oklahoma City | 35 | 30 | +17% |
| 13 | Glen E. Diacon, MDUrology · Ada | 35 | 34 | +3% |
| 15 | Caitlin Shepherd, MDUrology · Oklahoma City | 34 | 20 | +70% |
| 16 | Michael L. Peaster, MDUrology · Bartlesville | 33 | — | |
| 17 | Joseph L. Padalino, MDUrology · Tulsa | 31 | 22 | +41% |
| 18 | Basel S. Hassoun, MDUrology · Oklahoma City | 29 | 18 | |
| 18 | Charles T. Snyder, MDUrology · Oklahoma City | 29 | 23 | +26% |
| 18 | Richard B. Saint, MDUrology · Tulsa | 29 | 14 | |
| 18 | Shaun G. Grewal, MDUrology · Tulsa | 29 | 13 | |
| 22 | Michael Cookson, MDUrology · Oklahoma City | 28 | 21 | +33% |
| 23 | Michael S. Holzer, MDUrology · Oklahoma City | 27 | 25 | +8% |
| 24 | Marshall D. Shaw, MDUrology · Oklahoma City | 26 | 16 | |
| 24 | Jarrett D. Kruska, MDUrology · Enid | 26 | 12 | |
| 24 | Sean M. Doyle, MDUrology · Tulsa | 26 | 22 | +18% |
A rank counts procedures billed under the physician's own NPI (CPT 55700), in 2024, Medicare fee-for-service only. A surgeon who mostly treats younger or Medicare Advantage patients will rank lower than their total volume. Method and limits.